Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma
获得性 RAD51C 启动子甲基化缺失导致高级别浆液性卵巢癌对 PARP 抑制剂产生耐药性
期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-21-0774
Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Ghamsari, Mohammad Reza Eftekhariyan; Harrell, Maria I; Kee, Damien; Olesen, Inger; McNally, Orla; Traficante, Nadia; Australian Ovarian Cancer Study; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander; Wakefield, Matthew J; Scott, Clare L
肿瘤
表观遗传
肿瘤免疫
卵巢癌
RAD51
DNA甲基化
PARP